Nascent Pharma Holdings, Inc. (NASC)

Nascent Pharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 17, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2	1	6	21	4	9
Market Cap Growth	-38.16%	-85.56%	-72.61%	430.37%	-57.01%	-69.99%
Enterprise Value	19	18	23	33	11	14
Last Close Price	0.02	0.03	1.30	7.50	9.75	58.05
PS Ratio	2.08	0.39	0.86	4.56	2.32	3.99
PB Ratio	-0.22	-0.83	2.13	3.74	2.68	1.38
EV/Sales Ratio	18.75	8.26	3.40	7.12	6.49	6.23
Debt / Equity Ratio	-0.92	-9.16	3.46	1.30	1.41	0.02
Net Debt / Equity Ratio	-0.92	-9.13	3.43	1.22	1.10	0.01
Net Debt / EBITDA Ratio	-1.33	-1.50	-0.73	-0.70	-0.24	-0.01
Net Debt / FCF Ratio	36.54	-6.93	-2.35	-0.85	-0.81	-0.02
Asset Turnover	0.14	0.17	0.42	0.45	0.31	0.42
Inventory Turnover	2.47	0.99	1.78	1.11	0.49	1.37
Quick Ratio	0.12	0.34	0.54	0.43	1.11	2.57
Current Ratio	0.14	0.48	0.70	0.70	1.27	6.70
Return on Equity (ROE)	-	-1148.32%	-358.87%	-343.02%	-218.54%	-116.40%
Return on Assets (ROA)	-62.52%	-36.43%	-55.28%	-62.95%	-84.68%	-67.52%
Return on Capital Employed (ROCE)	76.30%	747.20%	-451.80%	-146.40%	-446.90%	-87.80%
Earnings Yield	-617.04%	-1172.96%	-259.58%	-57.98%	-224.36%	-64.10%
FCF Yield	-	-158.94%	-68.66%	-38.14%	-50.47%	-38.22%
Buyback Yield / Dilution	-608.91%	-252.66%	-165.79%	-470.01%	-71.71%	-45.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.